Mark Asset Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
Mark Asset Management's MRNA Position: Q3 2026 in Review
Mark Asset Management opened a new position in Moderna (MRNA) in Q3 2026: 4,314 shares worth $831K. The stake represents 0.06% of the portfolio and ranks #34 among its holdings. This is a return to the name: Mark Asset Management previously reported a position in MRNA as recently as Q3 2023.
Mark Asset Management first reported a position in MRNA in Q1 2021 and has held it in 11 quarters since. The position peaked at $19.7M in Q3 2021. 1,028 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.
- Mark Asset Management held 4,314 shares of Moderna worth $831K as of Q3 2026.
- Moderna was a new Mark Asset Management position in Q3 2026.
- Moderna made up 0.06% of Mark Asset Management's portfolio in Q3 2026, its #34 holding.
- Mark Asset Management first reported a position in Moderna in Q1 2021 and has held it in 11 quarters since.
- Mark Asset Management's Moderna position peaked at $19.7M in Q3 2021.
- 1,028 funds tracked by Wall St. Rank held Moderna as of Q3 2026.
Based on Mark Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.